Gloria

100% radiographic partial response rate achieved in patients on NOX-A12 + radiotherapy + bevacizumab, 83% with durable mRANO responses Two of 6 patients with tumor size reduction of >99% 12-month survival data expected in Q2…

MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Gloria Nelund, CEO & Founder of TriLinc Global, has joined AI for the Planet Advisory Board, a newly formed neutral and international alliance to be led by Startup Inside, with Boston…